Online supplemental material

Supplemental mateRIalS anD metHODS Microarray processing and data. The manufacturer’s protocols were followed for the determination of gene expression using the GeneChip Mouse Genome 430 2.0 array (Affymetrix). Hybridized arrays were scanned with a scanner (Gene Chip 3000), and image generation and feature extraction were performed using operating software (GeneChip; both from Affymetrix). All arrays passed the manufacturer’s quality specifications with respect to background and percent-present call rates. To generate the demonstrated heat map (Fig. 6 A), a list of 290 differentially expressed probe sets (Table S1) from Socs3 hKO and littermate control mice were identified by the following procedure. Raw microarray data were processed and analyzed with Bioconductor (1) and normalized with the Bioconductor GeneChip Robust Multi-Array Average package (2). After data normalization, genes with significant evidence for differential expression were identified using the limma package (3) in Bioconductor. p-values were calculated with a modified t test in conjunction with an empirical Bayes method to moderate the standard errors of the estimated log-fold changes. p-values were adjusted for multiplicity with the Bioconductor package q value (4). Before adjusting p-values for multiplicity, normalized values were nonspecifically filtered by omitting values whose interquartile range was <0.25. The final list of 290 probe sets (Table S1) was determined by further filtering for fold change > 1.5 and unadjusted P < 0.01 (for which we found that the false discovery rate = 0.084). The overall average intensity for the represented genes in the control littermate arrays was calculated and used as the baseline reference (black) in the demonstrated heatmap (Fig. 6 A). The shades of red or green in each bar on the heat map correspond to an intensity score relative to baseline. Affymetrix accession numbers for probe sets that were differentially regulated in Socs3 h-KO samples were submitted to NIH DAVID for analysis (Dennis, G., Jr., B.T. Sherman, D.A. Hosack, J. Yang, W. Gao, H.C. Lane, and R.A. Lempicki. 2003. Genome Biol. 4:P3). Pathways were categorized by Kyoto Encyclopedia of Genes and Genomes (KEGG) annotation. The percentage of total genes in a given enriched KEGG pathway (Fig. 6 B) was calculated by dividing the number of differentially expressed genes for each pathway identified via DAVID by the total number of genes in the pathway according to KEGG annotation.

[1]  T. Phan,et al.  Altered Migration, Recruitment, and Somatic Hypermutation in the Early Response of Marginal Zone B Cells to T Cell-Dependent Antigen1 , 2005, The Journal of Immunology.

[2]  Philip Lijnzaad,et al.  An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.

[3]  Gordon K. Smyth,et al.  limmaGUI: A graphical user interface for linear modeling of microarray data , 2004, Bioinform..

[4]  B. Clurman,et al.  Notch Activation Induces Endothelial Cell Cycle Arrest and Participates in Contact Inhibition: Role of p21Cip1 Repression , 2004, Molecular and Cellular Biology.

[5]  A. Karsan,et al.  Notch4-induced inhibition of endothelial sprouting requires the ankyrin repeats and involves signaling through RBP-Jkappa. , 2004, Blood.

[6]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[7]  R. Willemze,et al.  Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sézary Syndrome Identified by Gene Expression Analysis , 2004, Cancer Research.

[8]  Zhijin Wu,et al.  Preprocessing of oligonucleotide array data , 2004, Nature Biotechnology.

[9]  Linheng Li,et al.  Notch Activation Results in Phenotypic and Functional Changes Consistent With Endothelial-to-Mesenchymal Transformation , 2004, Circulation research.

[10]  A. Karsan,et al.  Notch4 Inhibits Endothelial Apoptosis via RBP-Jκ-dependent and -independent Pathways* , 2004, Journal of Biological Chemistry.

[11]  Carlos S. Moreno,et al.  MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer , 2003, Cell.

[12]  P. Kemmeren,et al.  Monitoring global messenger RNA changes in externally controlled microarray experiments , 2003, EMBO reports.

[13]  G. Rubin,et al.  Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Annick Harel-Bellan,et al.  The Retinoblastoma Protein Binds the Promoter of the Survival Gene bcl-2 and Regulates Its Transcription in Epithelial Cells through Transcription Factor AP-2 , 2002, Molecular and Cellular Biology.

[15]  A. Ström,et al.  The Anti-estrogenic Effect of All-trans-retinoic Acid on the Breast Cancer Cell Line MCF-7 Is Dependent on HES-1 Expression* , 2002, The Journal of Biological Chemistry.

[16]  A. Namane,et al.  Protein sequencing and identification using tandem mass spectrometry. Edited by Michael Kinter, Nicholas E. Sherman, published by Wiley-Interscience Series on Mass Spectrometry, 2000, 301 p. , 2002 .

[17]  H. Koeppen,et al.  Dynamics of notch expression during murine prostate development and tumorigenesis. , 2001, Cancer research.

[18]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Shiuan Chen,et al.  Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH). , 2001, Cancer research.

[20]  J. Herman,et al.  Methylation Patterns of the E-cadherin 5′ CpG Island Are Unstable and Reflect the Dynamic, Heterogeneous Loss of E-cadherin Expression during Metastatic Progression* , 2000, The Journal of Biological Chemistry.

[21]  M. Zeng,et al.  Hemoglobin induction in mouse macrophages. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Rajewsky,et al.  Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. , 1997, Immunity.

[23]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Naviaux,et al.  The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses , 1996, Journal of virology.

[25]  C. Bona,et al.  Germline V genes encode viable motheaten mouse autoantibodies against thymocytes and red blood cells. , 1990, Journal of immunology.

[26]  S. Tonegawa,et al.  A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene , 1983, Cell.

[27]  J. Banerji,et al.  A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes , 1983, Cell.

[28]  G E Wu,et al.  Nucleotide sequence of a chromosomal rearranged lambda 2 immunoglobulin gene of mouse , 1982, Nucleic Acids Res..

[29]  S. Pillai,et al.  Marginal zone B cells. , 2005, Annual review of immunology.

[30]  B. Haines,et al.  Germline diversity of the expressed BALB/c VhJ558 gene family. , 2001, Molecular immunology.

[31]  B. Bogen,et al.  A rearranged lambda 2 light gene chain retards but does not exclude kappa and lambda 1 expression. , 1991, European journal of immunology.